ModivCare Inc. (MODV)
USD 1.46
(5.8%)
USD 1.46
(5.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -139.94 Million USD | -33.23% |
| 2022 | 57.08 Million USD | -36.41% |
| 2021 | 89.77 Million USD | -27.11% |
| 2020 | 123.15 Million USD | 2733.83% |
| 2019 | -4.67 Million USD | -119.26% |
| 2018 | 24.27 Million USD | -32.63% |
| 2017 | 36.03 Million USD | 318.16% |
| 2016 | 8.61 Million USD | -64.09% |
| 2015 | 23.99 Million USD | -43.33% |
| 2014 | 42.34 Million USD | 9.59% |
| 2013 | 38.63 Million USD | 59.64% |
| 2012 | 24.2 Million USD | -33.95% |
| 2011 | 36.63 Million USD | -36.06% |
| 2010 | 57.3 Million USD | 6.66% |
| 2009 | 53.72 Million USD | 135.98% |
| 2008 | -149.31 Million USD | -680.72% |
| 2007 | 25.71 Million USD | 66.52% |
| 2006 | 15.44 Million USD | -6.4% |
| 2005 | 16.49 Million USD | 42.49% |
| 2004 | 11.57 Million USD | 68.3% |
| 2003 | 6.87 Million USD | 2723.05% |
| 2002 | -262.26 Thousand USD | -100.46% |
| 2001 | 57.08 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.39 Million USD | -121.66% |
| 2024 Q2 | 6.38 Million USD | 287.98% |
| 2023 Q3 | 12.04 Million USD | 106.85% |
| 2023 Q4 | 15.67 Million USD | 30.17% |
| 2023 FY | 38.11 Million USD | -33.23% |
| 2023 Q1 | 8.09 Million USD | 22.38% |
| 2023 Q2 | -175.76 Million USD | -2270.45% |
| 2022 Q3 | 12.44 Million USD | -46.22% |
| 2022 Q4 | 6.61 Million USD | -46.84% |
| 2022 FY | 57.08 Million USD | -36.41% |
| 2022 Q2 | 23.14 Million USD | 55.61% |
| 2022 Q1 | 14.87 Million USD | -26.59% |
| 2021 Q3 | 13.12 Million USD | -52.39% |
| 2021 Q1 | 28.81 Million USD | 37.63% |
| 2021 FY | 89.77 Million USD | -27.11% |
| 2021 Q2 | 27.56 Million USD | -4.33% |
| 2021 Q4 | 20.26 Million USD | 54.38% |
| 2020 FY | 123.15 Million USD | 2733.83% |
| 2020 Q1 | 10.04 Million USD | 32.98% |
| 2020 Q2 | 48.84 Million USD | 386.24% |
| 2020 Q3 | 43.33 Million USD | -11.28% |
| 2020 Q4 | 20.93 Million USD | -51.69% |
| 2019 Q3 | 16.98 Million USD | 622.68% |
| 2019 FY | -4.67 Million USD | -119.26% |
| 2019 Q1 | 3.44 Million USD | 596.54% |
| 2019 Q2 | -3.25 Million USD | -194.45% |
| 2019 Q4 | 7.55 Million USD | -55.53% |
| 2018 Q2 | -9.31 Million USD | -197.02% |
| 2018 Q4 | -693 Thousand USD | -110.09% |
| 2018 FY | 24.27 Million USD | -32.63% |
| 2018 Q1 | 9.6 Million USD | -43.32% |
| 2018 Q3 | 6.86 Million USD | 173.73% |
| 2017 Q2 | 5.99 Million USD | -11.62% |
| 2017 FY | 36.03 Million USD | 318.16% |
| 2017 Q4 | 16.93 Million USD | 168.47% |
| 2017 Q3 | 6.3 Million USD | 5.17% |
| 2017 Q1 | 6.78 Million USD | 141.92% |
| 2016 FY | 8.61 Million USD | -64.09% |
| 2016 Q4 | -16.19 Million USD | -265.34% |
| 2016 Q3 | 9.79 Million USD | -26.89% |
| 2016 Q2 | 13.39 Million USD | 5.86% |
| 2016 Q1 | 12.65 Million USD | 166.77% |
| 2015 Q3 | 6.87 Million USD | -65.47% |
| 2015 Q2 | 19.92 Million USD | -10.84% |
| 2015 Q1 | 22.34 Million USD | 48.73% |
| 2015 FY | 23.99 Million USD | -43.33% |
| 2015 Q4 | -18.95 Million USD | -375.53% |
| 2014 Q1 | 12.08 Million USD | 98.03% |
| 2014 Q2 | 13.46 Million USD | 11.45% |
| 2014 Q3 | 1.83 Million USD | -86.36% |
| 2014 Q4 | 15.02 Million USD | 717.8% |
| 2014 FY | 42.34 Million USD | 9.59% |
| 2013 Q3 | 7.97 Million USD | -30.36% |
| 2013 Q2 | 11.45 Million USD | -12.61% |
| 2013 FY | 38.63 Million USD | 59.64% |
| 2013 Q4 | 6.1 Million USD | -23.52% |
| 2013 Q1 | 13.1 Million USD | 58.73% |
| 2012 Q3 | 4.98 Million USD | 14.03% |
| 2012 Q4 | 8.25 Million USD | 65.72% |
| 2012 FY | 24.2 Million USD | -33.95% |
| 2012 Q1 | 6.59 Million USD | -6.53% |
| 2012 Q2 | 4.36 Million USD | -33.74% |
| 2011 Q3 | 5.93 Million USD | -40.23% |
| 2011 Q1 | 13.71 Million USD | 22.16% |
| 2011 Q2 | 9.93 Million USD | -27.54% |
| 2011 Q4 | 7.05 Million USD | 18.77% |
| 2011 FY | 36.63 Million USD | -36.06% |
| 2010 Q4 | 11.22 Million USD | 22.29% |
| 2010 Q2 | 16.98 Million USD | -14.69% |
| 2010 Q3 | 9.17 Million USD | -45.97% |
| 2010 Q1 | 19.91 Million USD | 33.48% |
| 2010 FY | 57.3 Million USD | 6.66% |
| 2009 FY | 53.72 Million USD | 135.98% |
| 2009 Q1 | 15.04 Million USD | 146.54% |
| 2009 Q4 | 14.91 Million USD | 52.35% |
| 2009 Q3 | 9.79 Million USD | -29.93% |
| 2009 Q2 | 13.97 Million USD | -7.09% |
| 2008 FY | -149.31 Million USD | -680.72% |
| 2008 Q4 | -32.31 Million USD | 76.59% |
| 2008 Q3 | -138.07 Million USD | -1463.21% |
| 2008 Q2 | 10.12 Million USD | -7.48% |
| 2008 Q1 | 10.94 Million USD | 22.95% |
| 2007 Q1 | 5.32 Million USD | 425.11% |
| 2007 Q2 | 6.03 Million USD | 13.24% |
| 2007 FY | 25.71 Million USD | 66.52% |
| 2007 Q3 | 5.45 Million USD | -9.63% |
| 2007 Q4 | 8.9 Million USD | 63.35% |
| 2006 Q2 | 5.33 Million USD | 10.76% |
| 2006 Q1 | 4.81 Million USD | 12.2% |
| 2006 Q4 | 1.01 Million USD | -76.31% |
| 2006 FY | 15.44 Million USD | -6.4% |
| 2006 Q3 | 4.28 Million USD | -19.69% |
| 2005 Q1 | 3.52 Million USD | -2.05% |
| 2005 Q2 | 4.05 Million USD | 14.81% |
| 2005 Q3 | 593.86 Thousand USD | -85.34% |
| 2005 Q4 | 4.29 Million USD | 622.4% |
| 2005 FY | 16.49 Million USD | 42.49% |
| 2004 Q2 | 2.49 Million USD | 30.4% |
| 2004 FY | 11.57 Million USD | 68.3% |
| 2004 Q1 | 1.91 Million USD | -6.15% |
| 2004 Q4 | 3.6 Million USD | 0.97% |
| 2004 Q3 | 3.56 Million USD | 42.98% |
| 2003 Q4 | 2.03 Million USD | 20.6% |
| 2003 FY | 6.87 Million USD | 2723.05% |
| 2003 Q3 | 1.69 Million USD | -1.63% |
| 2003 Q2 | 1.71 Million USD | -81.94% |
| 2003 Q1 | 9.51 Million USD | 0.0% |
| 2002 FY | -262.26 Thousand USD | -100.46% |
| 2001 Q3 | 13.12 Million USD | -52.39% |
| 2001 Q4 | 20.17 Million USD | 53.74% |
| 2001 FY | 57.08 Million USD | 0.0% |
| 2001 Q2 | 27.56 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 127.625% |
| Addus HomeCare Corporation | 90.95 Million USD | 253.861% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 1575.757% |
| Amedisys, Inc. | 156.39 Million USD | 189.483% |
| Astrana Health, Inc. | 84.61 Million USD | 265.395% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 1833.722% |
| IMAC Holdings, Inc. | -6.37 Million USD | -2095.056% |
| biote Corp. | 28.65 Million USD | 588.348% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -1037.4% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 224.161% |
| COMPASS Pathways plc | -136.91 Million USD | -2.211% |
| DocGo Inc. | 15.05 Million USD | 1029.566% |
| The Ensign Group, Inc. | 255.36 Million USD | 154.802% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 324.423% |
| InnovAge Holding Corp. | -23.18 Million USD | -503.736% |
| The Joint Corp. | -2.07 Million USD | -6650.609% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 26.007% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -791.163% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 331395.867% |
| Option Care Health, Inc. | 314.59 Million USD | 144.484% |
| P3 Health Partners Inc. | -167.86 Million USD | 16.629% |
| P3 Health Partners Inc. | -167.86 Million USD | 16.629% |
| The Pennant Group, Inc. | 25.16 Million USD | 656.025% |
| Surgery Partners, Inc. | 328 Million USD | 142.666% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -4746.449% |
| Talkspace, Inc. | -23.2 Million USD | -502.982% |
| Talkspace, Inc. | -23.2 Million USD | -502.982% |
| The Oncology Institute, Inc. | -77.01 Million USD | -81.706% |
| The Oncology Institute, Inc. | -77.01 Million USD | -81.706% |